Regulation of tumor angiogenesis by microRNAs: State of the art
NH Goradel, N Mohammadi… - Journal of cellular …, 2019 - Wiley Online Library
MicroRNAs (miRNAs, miRs) are small (21–25 nucleotides) endogenous and noncoding
RNAs involved in many cellular processes such as apoptosis, development, proliferation …
RNAs involved in many cellular processes such as apoptosis, development, proliferation …
Non-coding RNAs in lung cancer: emerging regulators of angiogenesis
Y Liao, X Wu, M Wu, Y Fang, J Li, W Tang - Journal of Translational …, 2022 - Springer
Lung cancer is the second cancer and the leading cause of tumor-related mortality
worldwide. Angiogenesis is a crucial hallmark of cancer development and a promising target …
worldwide. Angiogenesis is a crucial hallmark of cancer development and a promising target …
Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1
Background & Aims Clinical evidence has indicated a close link between non-alcoholic fatty
liver disease (NAFLD) and cardiovascular disease (CVD). However, the underlying …
liver disease (NAFLD) and cardiovascular disease (CVD). However, the underlying …
Targeted miR-34a delivery with PD1 displayed bacterial outer membrane vesicles-coated zeolitic imidazolate framework nanoparticles for enhanced tumor therapy
C Cui, Q He, J Wang, J Kang, W Ma, Y Nian… - International Journal of …, 2023 - Elsevier
MicroRNA (miRNA) has been widely used as an effective gene drug for tumor therapy, but
its chemical instability limited its therapeutic application in vivo. In this research, we fabricate …
its chemical instability limited its therapeutic application in vivo. In this research, we fabricate …
miR‐1‐3p and miR‐206 sensitizes HGF‐induced gefitinib‐resistant human lung cancer cells through inhibition of c‐Met signalling and EMT
D Jiao, J Chen, Y Li, X Tang, J Wang… - Journal of Cellular …, 2018 - Wiley Online Library
Hepatocyte growth factor (HGF) overexpression is an important mechanism in acquired
epidermal growth factor receptor (EGFR) kinase inhibitor gefitinib resistance in lung cancers …
epidermal growth factor receptor (EGFR) kinase inhibitor gefitinib resistance in lung cancers …
Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/miR-1-3p axis in bladder cancer
Background Abnormal glycosylation in a variety of cancer types is involved in tumor
progression and chemoresistance. Glycosyltransferase C1GALT1, the key enzyme in …
progression and chemoresistance. Glycosyltransferase C1GALT1, the key enzyme in …
Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer
M Li, Y Liu, X Zhang, J Liu, P Wang - Gene, 2018 - Elsevier
An increasing number of studies have revealed that long noncoding RNA (lncRNA) and
circular RNA (circRNA) participate in the carcinogenesis and progression of tumors …
circular RNA (circRNA) participate in the carcinogenesis and progression of tumors …
[HTML][HTML] Role of MicroRNA-30c in cancer progression
W Han, H Cui, J Liang, X Su - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs or miRs) is a non-coding small RNA of a type of 18~ 24 nucleotide-
regulated gene that has been discovered in recent years. It mainly degrades the target gene …
regulated gene that has been discovered in recent years. It mainly degrades the target gene …
LINC00941 promotes progression of non-small cell lung cancer by sponging miR-877-3p to regulate VEGFA expression
MH Ren, SI Chen, LG Wang, WX Rui, P Li - Frontiers in oncology, 2021 - frontiersin.org
Long noncoding RNAs (lncRNAs) play critical roles in carcinoma occurrence and
metastasis. LINC00941 has been found to mediate the development of gastric cancer, and …
metastasis. LINC00941 has been found to mediate the development of gastric cancer, and …
MicroRNAs as early diagnostic biomarkers for non-small cell lung cancer
X Liang, Q Wu, Y Wang, S Li - Oncology Reports, 2022 - spandidos-publications.com
Lung cancer (LC) is the leading cause of cancer-related death, with high incidence and
mortality rate. Early diagnosis and treatment of LC are imperative to improve the 5-year …
mortality rate. Early diagnosis and treatment of LC are imperative to improve the 5-year …